113 related articles for article (PubMed ID: 32449122)
1. Qi-activating quercetin alleviates mitochondrial dysfunction and neuroinflammation in vivo and in vitro.
Kang S; Piao Y; Kang YC; Lim S; Pak YK
Arch Pharm Res; 2020 May; 43(5):553-566. PubMed ID: 32449122
[TBL] [Abstract][Full Text] [Related]
2. DA-9805 protects dopaminergic neurons from endoplasmic reticulum stress and inflammation.
Kang S; Piao Y; Kang YC; Lim S; Pak YK
Biomed Pharmacother; 2022 Jan; 145():112389. PubMed ID: 34775235
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K
J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells.
Piao Y; Kim HG; Oh MS; Pak YK
Biochim Biophys Acta; 2012 May; 1820(5):577-85. PubMed ID: 21856379
[TBL] [Abstract][Full Text] [Related]
5. Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB.
Park WH; Kang S; Piao Y; Pak CJ; Oh MS; Kim J; Kang MS; Pak YK
J Ethnopharmacol; 2015 Nov; 174():37-44. PubMed ID: 26231448
[TBL] [Abstract][Full Text] [Related]
6. Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.
Ghosh A; Langley MR; Harischandra DS; Neal ML; Jin H; Anantharam V; Joseph J; Brenza T; Narasimhan B; Kanthasamy A; Kalyanaraman B; Kanthasamy AG
J Neuroimmune Pharmacol; 2016 Jun; 11(2):259-78. PubMed ID: 26838361
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
Ghosh A; Tyson T; George S; Hildebrandt EN; Steiner JA; Madaj Z; Schulz E; Machiela E; McDonald WG; Escobar Galvis ML; Kordower JH; Van Raamsdonk JM; Colca JR; Brundin P
Sci Transl Med; 2016 Dec; 8(368):368ra174. PubMed ID: 27928028
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress.
You LH; Li Z; Duan XL; Zhao BL; Chang YZ; Shi ZH
Brain Res; 2016 Jul; 1642():33-42. PubMed ID: 27017962
[TBL] [Abstract][Full Text] [Related]
9. Gas1 up-regulation is inducible and contributes to cell apoptosis in reactive astrocytes in the substantia nigra of LPS and MPTP models.
Sun XL; Chen BY; Zhao HK; Cheng YY; Zheng MH; Duan L; Jiang W; Chen LW
J Neuroinflammation; 2016 Jul; 13(1):180. PubMed ID: 27391369
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
11. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial alterations in Parkinson's disease human samples and cellular models.
Zilocchi M; Finzi G; Lualdi M; Sessa F; Fasano M; Alberio T
Neurochem Int; 2018 Sep; 118():61-72. PubMed ID: 29704589
[TBL] [Abstract][Full Text] [Related]
13. Ferulic Acid Rescues LPS-Induced Neurotoxicity via Modulation of the TLR4 Receptor in the Mouse Hippocampus.
Rehman SU; Ali T; Alam SI; Ullah R; Zeb A; Lee KW; Rutten BPF; Kim MO
Mol Neurobiol; 2019 Apr; 56(4):2774-2790. PubMed ID: 30058023
[TBL] [Abstract][Full Text] [Related]
14. Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.
Jeitner TM; Kalogiannis M; Krasnikov BF; Gomolin I; Peltier MR; Moran GR
Toxicol Sci; 2016 Jun; 151(2):388-402. PubMed ID: 27026709
[TBL] [Abstract][Full Text] [Related]
15. Hyperoside inhibits lipopolysaccharide-induced inflammatory responses in microglial cells via p38 and NFκB pathways.
Fan HH; Zhu LB; Li T; Zhu H; Wang YN; Ren XL; Hu BL; Huang CP; Zhu JH; Zhang X
Int Immunopharmacol; 2017 Sep; 50():14-21. PubMed ID: 28622577
[TBL] [Abstract][Full Text] [Related]
16. NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease.
Sirabella R; Sisalli MJ; Costa G; Omura K; Ianniello G; Pinna A; Morelli M; Di Renzo GM; Annunziato L; Scorziello A
Cell Death Dis; 2018 Jun; 9(7):725. PubMed ID: 29941946
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
[TBL] [Abstract][Full Text] [Related]
18. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
19. Quercetin Attenuates Manganese-Induced Neuroinflammation by Alleviating Oxidative Stress through Regulation of Apoptosis, iNOS/NF-κB and HO-1/Nrf2 Pathways.
Bahar E; Kim JY; Yoon H
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914791
[TBL] [Abstract][Full Text] [Related]
20. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
